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Weak motifCollaboration of transcription factors (TFs) and their recognition motifs in DNA is the result of coevolu-
tion and forms the basis of gene regulation. However, the way how these short genomic sequences con-
tribute to setting the level of gene products is not understood in sufficient detail. The biological problem
to be solved by the cell is complex, because each gene requires a unique regulatory network in each cel-
lular condition using the same genome. Thus far, only some components of these networks have been
uncovered. In this review, we compiled the features and principles of the motif grammar, which dictates
the characteristics and thus the likelihood of the interactions of the binding TFs and their coregulators.
We present how sequence features provide specificity using, as examples, two major TF superfamilies,
the bZIP proteins and nuclear receptors. We also discuss the phenomenon of ‘‘weak” (low affinity) bind-
ing sites, which appear to be components of several important genomic regulatory regions, but paradox-
ically are barely detectable by the currently used approaches. Assembling the complete set of regulatory
regions composed of both weak and strong binding sites will allow one to get more comprehensive lists
of factors playing roles in gene regulation, thus making possible the deeper understanding of regulatory
networks.
 2020 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and
Structural Biotechnology. This is an open access article under the CC BY-NC-ND license (http://creative-
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Fig. 1. Classification of transcription factor binding sites. Monomer binding sites,
which can be bound by single TFs, often add up to larger units. Two, essentially
identical half-sites can be bound by homodimers formed by identical TFs (blue
circles, right) or heterodimers formed by related TF partners (blue and green circle).
Composite elements are built up form at least two monomer binding sites specific
for different TFs (blue and dark purple circles). Boxes colored according to TFs
represent monomer binding sites. (For interpretation of the references to colour in
this figure legend, the reader is referred to the web version of this article.)
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DNA binding by transcription factors (TFs) takes place at recog-
nition sites that meet their specific sequence requirements (motifs)
throughout the genome. However, there is an incredible redun-
dancy of these sites for a number of reasons. DNA sequence motifs
generally contain both strictly invariable and degenerate nucleo-
tides. The latter means that in certain positions two, three, or even
four different nucleotides can be tolerated by the binding TF(s),
without necessarily changing the binding affinity. As a result, a
motif with four invariable nucleotides and two interchangeable
ones ([1/4]4  [2/4]2) or three invariable and four interchangeable
ones ([1/4]3  [2/4]4) can be found in each kilobase of a genome by
chance. In a typical mammalian genome, this can result in millions
of putative binding sites per TF. However, most of these are hidden
in the chromatin structure, so their accessibility is key to establish
specific DNA-protein interactions. Therefore, out of the millions of
putative binding sites, only a fraction (hundreds to tens of thou-
sands) is indeed available and occupied in the individual cells at
a certain moment and condition, and even fewer have direct func-
tional consequences. The motifs characterizing these binding sites
evolved along with the TFs, especially with their DNA binding
domains (DBDs) to provide specific contacts during the course of
phylogenesis and ontogenesis. Accordingly, members of most
major TF (super)families, such as the basic leucine zipper (bZIP),
homeodomain, and high mobility group (HMG) proteins, nuclear
receptors (NRs), as well as the TATA-binding protein (TBP) and
CCAAT-binding complex (CBC), can be found in all metazoan, and
except for NRs, also in lower eukaryotes [1–6].2. Interaction between DNA and transcription factors
Beyond the sequence-specific DNA binding of the major groove,
multiple factors contribute to DNA-TF interactions, including the
binding of the sugar-phosphate backbone or the base pairs from
the side of the minor groove, which latter allows an additional,
basically binary sequence readout [7]. Interferon regulatory factors
(IRFs) and certain NRs show dual sequence recognition, as these
bind in both the major and minor grooves at the same time [8,9].
TBP, CBC, and HMG protein family members, in contrast, bind pri-
marily in the minor groove; however, their recognition sequences
allow the specific bending of DNA, which is critical for the interac-
tion and downstream functions [5,6,10]. Like in these cases, the
composition of motifs determines the possible local conformations
of DNA, which can fit the interaction surfaces of DNA-binding pro-
teins. These so-called shape motifs, which can be achieved even by
diverse sequences, imply an additional layer of specificity for
sequence motifs [7,11–14]. Similarly, DNA methylation also affects
DNA-protein contacts. The binding of methylated GC-rich
sequences by TFs is generally greatly limited [15]. For instance,
interaction between CCCTC-binding factor (CTCF) and the insulator
elements is hindered by DNA methylation [16,17]. In contrast, the
repressor Kaiso shows DNA methylation-dependent binding
[18,19].3. The hierarchy of binding sites: From monomer binding sites
to enhancers
TFs work in collaboration with other TFs and non-DNA-binding
coregulators, forming multi-protein complexes and establishing
the connection between promoters and enhancers/silencers to reg-
ulate gene expression. Promoters, by definition, contain motifs that
facilitate the recruitment of general TFs and RNA polymerase,
resulting in basal gene expression levels. Enhancers, in turn, con-
tain cell type-specific motifs, which recruit TFs responsible forthe induction of phenotype-determining genes from a distance
via looping. Silencers have the opposite effect to enhancers,
although this is due to the binding TFs, which can take part in gene
regulation as activators, repressors, or collaborators. As a result,
the same sequence can behave either as an enhancer or silencer
depending on the cellular context [20]. For simplicity, we will refer
to all these, typically promoter-distal regulatory regions as
enhancers.
Genes are regulated by various numbers of TF binding sites.
Conserved gene regulatory regions, such as promoters and certain
enhancers, can be hundreds of nucleotides long, including dozens
of binding sites, while most enhancers have evolved recently and
consist of a few or even one single binding site [21]. Several TFs
are functional as monomers and interact with single monomer
binding sites with high affinity, although these should be long
enough – usually at least six invariable nucleotides – to provide
specific surface for the required amount of molecular contacts.
Most TFs bind DNA as dimers, and these can be further assembled
to larger complexes capable of DNA binding at multiple surfaces. In
line with these, monomer and dimer binding sites can be arranged
into more complex elements, and ultimately, add up to collaborat-
ing promoters and enhancers. Within these functional sequences,
monomer binding sites can be located in several ways relative to
each other; however, their distribution is not fully random – there
are regularities within the line of elements to make possible inter-
actions with the TFs proper for cell type-specific gene regulation.
Moreover, the joint recruitment of multiple TFs can make subopti-
mal binding sites accessible, thus enhancers (and promoters) can
contain weak binding sites [22]. For instance, several developmen-
tal genes are regulated by both optimal and suboptimal binding
sites with an optimized relative distribution, while experimental
improvement of weak binding sites cause ectopic gene expression
[23–26].4. Transcription factors and composite elements
Most TFs form dimers, in which both proteins are capable of
DNA binding at dimer binding sites, thus creating the possibility
or further increasing the specificity of DNA-protein interactions
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Author's Personal Copy(Fig. 1). Dimerization can take place with the involvement of two
identical TFs (homodimers), TFs from the same (super)family, or
even from families of different origin (heterodimers) [7,27–29].
For instance, bZIP proteins have an integrated DNA-binding and
dimerization domain, which enables a flexible choice of dimerizing
partners within the superfamily and specific motif recognition
depending on the partners [1,30–32]. Steroid hormone receptors
and dimeric orphan receptors (NR superfamily) form homodimers
or heterodimers with NRs from the same family, while NRs from
most NR1 families (NR1A, B, C, H, I) form heterodimers with the
retinoid X receptors (RXRs, NR2B) [2,33]. In this superfamily, two
zinc fingers provide sequence-specific recognition and also con-
tribute to dimerization.
Although most known dimers are assembled from closely
related TFs, currently, there is an emerging number of newly iden-
tified heterodimers built up from TFs from different protein (su-
per)families [28–29]. While the former group of dimers binds
two associated, substantially identical monomer binding sites –
so-called half-sites –, the latter binds composite elements of differ-
ent monomer binding sites (Fig. 1). The protein product of myeloid
ecotropic viral integration site 1 (MEIS1), for example, binds sev-
eral composite elements in collaboration with members of other
homeodomain protein families [27,34]. It also has a homodimer
binding site; however, the DBDs within the supposed homodimer
are on the opposite side of DNA, so there is no contact between
them. In contrast, in the case of MEIS1/distal-less homeobox 3
(DLX3) heterodimers, the DBD of DLX3 distorts DNA, narrows
and binds the minor groove, and then it is capable of interacting
more closely with the DBD of MEIS1 [27]. Both examples show
contacts that are primarily independent of TF-TF interactions and
suggest that dimer binding sites can have major roles both in TF
binding and dimerization, although other TFs, like bZIP proteins,
have interaction surfaces large and compatible enough to provide
dimerization even in the absence of specific DNA segments.
There are also long known heterodimers and composite ele-
ments with critical developmental and cell lineage-determining
roles. Collaboration of octamer-binding transcription factor 4
(OCT4, homeodomain) and sex determining region Y (SRY)-box 2
(SOX2, HMG) on their shared composite elements is a key for the
maintenance of embryonic stem cells [6,35]. Purine-rich nucleic
acid binding protein 1 (PU.1; erythroblast transformation-specific
[ETS] superfamily), in turn, is indispensable for the development
and maintenance of most white blood cells and tightly collaborates
with IRF4 or IRF8 on several kinds of composite elements [36,37].
Within these elements, the core nucleotide tetramers tandemly
follow each other, but their order and spacing are different. The
ETS:IRF composite element (EICE) with two spacer nucleotides
and ETS:IRF response element (EIRE) with three spacer nucleotidesTable 1
Features of motif and enhancer (promoter) grammar.
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Sequence features that contribute (+) or do not contribute () to motif/enhancer com
basically identical monomer binding sites (half-sites), so their orientation, spacing, stren
other dimer binding sites the type and order can also be determinate features (+). Unli
expression is uncertain (‘?’).are bound by PU.1 and IRF4/8 in this order, while the IRF:ETS com-
posite sequence (IECS) with two or three spacer nucleotides is
bound in the opposite order by the two proteins. These motifs
imply different ways of dimerization, although the transcriptional
effects of different conformations of the formed ternary complexes
are not known [38–41]. There are additional ETS proteins that form
heterodimers with TFs of different origins and have composite ele-
ments accordingly. Out of these, several elements, such as that of
the glial cells missing transcription factor 1 (GCM1)/ETS-like 1
(ELK1) heterodimer, lack flanking (spacer) nucleotides or contain
altered ones [27]. Thereby, in certain cases, the knowledge of
canonical monomer binding sites is not sufficient to cover all ele-
ments in use, but also dimer-specific information should be used
to cover all binding sites (the cistrome) of a certain TF.
5. Motif grammar
Monomer binding sites within longer gene regulatory units can
follow each other in several ways to provide specificity and selec-
tivity. In the simplest case, half-sites can form an asymmetric
head-to-tail (tandem or direct repeat, DR) or symmetric (inverted
or everted) repeat (IR or ER, respectively); in addition, the distance
between them can also vary. For instance, within the signal trans-
ducer and activator of transcription (STAT) family all dimers are
capable of binding the quasi-palindromic, interferon c-activated
sequence (GAS) with three spacer nucleotides (50-TTC(T/C)N(A/G)
GAA-30), while STAT6 homodimers prefer four nucleotide-long
spacers [42–44]. In the case of composite elements and higher-
order regulatory sequences, besides the orientation and spacing,
the type, number, and order of monomer binding sites also have
significance, not to mention the strength (affinity) of the individual
binding sites and the shape information encoded in DNA (Table 1).
These sequence features that determine the quality, order, orienta-
tion, and putative interactions of the binding TFs and their coregu-
lators are termed motif grammar, or promoter/enhancer grammar,
if we consider entire regulatory regions [23,45]. To illustrate how
sequence features determine specific DNA-TF interactions, we dis-
cuss in the next sections the basic sequence requirements of two
major TF groups, the bZIP and NR superfamilies, involved in impor-
tant physiological and pathological processes [1,2]. Furthermore,
we listed in Table 2 all elements of this review, mentioned in con-
nection with motif grammar.
6. Motif grammar of bZIP proteins
In line with the symmetric basic structure of bZIP dimers, the
direction of bZIP half-sites is always convergent, and the spacer
appears to be integral part of the half-sites (Fig. 2). The mostEnhancer grammar Features
Cluster of elements
+ Gene regulation
6– hundreds Size (bp)







plexity (specificity) are indicated. Homodimer binding sites, for instance, contain
gth, and shape can vary (+), but their type and order are self-evident (), while in
ke in the case of enhancers (promoters), the effect of individual elements on gene
Table 2




MEIS1/MEIS1 Jolma et al. 2015 [27]
MEIS1/DLX3 Jolma et al. 2015 [27]
OCT4/SOX2 Rodda et al. 2005 [35]
IRF/IRF (ISRE) Fujii et al. 1999 [9]
PU.1/IRF4/8 (EICE/EIRE) Meraro et al. 2002 [38]
IRF4/8/PU.1 (IECS) Tamura et al. 2005 [39]
GCM1/ELK1 Jolma et al. 2015 [27]
STAT/STAT (GAS) Pearse et al. 1993 [42], Seidel et al. 1995 [43]
STAT6/STAT6 Li et al. 2016 [44]
JUN/FOS (TRE) Deppmann et al. 2006 [46], Amoutzias et al. 2007
[1], Cohen et al. 2018 [31]
CREB, ATF, JUN dimers
(CRE)
Deppmann et al. 2006 [46], Amoutzias et al. 2007
[1], Cohen et al. 2018 [31]
sMAF/CNC (MARE) Inamdar et al. 1996 [47], Newman et al. 2003 [30]
lMAF/lMAF (MARE) Kataoka et al. 1994 [49], Newman et al. 2003 [30],
Kurokawa et al. 2009 [48]
C/EBP/C/EBP Cohen et al. 2018 [31]
C/EBP/ATF4 (CARE) Cohen et al. 2018 [31]
JUNB/BATF/IRF4/8 (AICE) Glasmacher et al. 2012 [51]
NR3C dimers (IR3) Mangelsdorf et al. 1995 [2]
ER/ER (ERE) Mangelsdorf et al. 1995 [2]
RAR/RXR (RARE, DR0-
2,5,8, IR0)
Rastinejad et al. 1995 [59], Moutier et al. 2012
[53], Simandi et al. 2018 [52]
PPAR/RXR (PPRE) IJpenberg et al. 1997 [8], Chandra et al. 2008 [55],
Nagy et al. 2020 [67]
REV-ERB/REV-ERB (Rev-
DR2)
IJpenberg et al. 1997 [8], Sierk et al. 2001 [54]
RXR/LXR (LXRE) Feldmann et al. 2013 [58], Lou et al. 2014 [57]
RXR/VDR (VDRE) Rastinejad et al. 1995 [59], Orlov et al. 2012 [60]
RXR/THR (THRE) Rastinejad et al. 1995 [59], Grøntved et al. 2015
[61]
ROR (RORE) IJpenberg et al. 1997 [8]
NR3B Johnston et al. 1997 [65]
NR4A Wilson et al. 1992 [64]
NR5A Lala et al. 1992 [63]
MEIS1, myeloid ecotropic viral integration site 1; DLX3, distal-less homeobox 3;
OCT4, octamer-binding transcription factor 4; SOX2, sex determining region Y
(SRY)-box 2; IRF, interferon regulatory factor; ISRE, interferon-stimulated response
element; PU.1, purine-rich nucleic acid binding protein 1; ETS, erythroblast trans-
formation-specific; EICE/EIRE, ETS:IRF composite/response element; IECS, IRF:ETS
composite sequence; GCM1, glial cells missing transcription factor 1; ELK1, ETS-like
1; STAT, signal transducer and activator of transcription; GAS, interferon c-acti-
vated sequence; RARE, retinoic acid response element; further abbreviations for
bZIP and NR proteins are listed in Figs. 2 and 3.
Fig. 2. Schematic representation of major bZIP motifs. TRE/CRE (50-TGA(C/G)-30)
and MARE (50-TGCTGA(C/G)-30) half-sites are marked by blue arrows, C/EBP half
sites are marked by green arrows, and spacer nucleotides are marked by black dots.
Schematic motif logos and motif/protein names are indicated (TRE, TPA response
element; CRE, cAMP response element; CREB, CRE binding protein; ATF, activating
transcription factor; MAF, musculoaponeurotic fibrosarcoma protein; CNC,
cap0n0collar-type bZIP protein; C/EBP, CCAAT/enhancer-binding protein; (s)MARE,
(small) MAF response element; CARE, C/EBP:ATF response element). (For interpre-
tation of the references to colour in this figure legend, the reader is referred to the
web version of this article.)
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Author's Personal Copyancient bZIP motifs share the same half site and differ in spacer
length [1]: 12-O-tetradecanoylphorbol-13-acetate (TPA) response
element (TRE) contains a one-nucleotide long spacer (50-TGA(C/G
)TCA-30), while cAMP-response element (CRE) has two spacer
nucleotides (50-TGACGTCA-30). The former is optimal for members
of the activator protein 1 (AP-1) families, primarily FOS/JUN het-
erodimers; and the latter can be bound by dimers of CRE binding
protein (CREB)/activating transcription factor (ATF) family mem-
bers (Fig. 2). Nevertheless, JUN proteins are capable of binding both
TRE and CRE by forming heterodimers with different partners [46].
Certain bZIP dimers are specialized for longer sequences. Muscu-
loaponeurotic fibrosarcoma (MAF) proteins, for example, recognize
MAF response elements (MAREs) with 50-TGCTGA(C/G)-30 half-
sites, which can be considered as upstream extended TRE/CRE
half-sites [47,48]. Small MAFs form heterodimers basically with
Cap’n’collar (CNC)-type bZIP proteins, which, in turn, also bind
the short 50-TGA(C/G)-30 half-site, so their shared composite ele-
ment is essentially a TRE, extended by three nucleotides to one
direction. In contrast, dimers of large MAFs bind the inverted
repeat of MARE half-sites with a single C/G nucleotide or both in
the middle (Fig. 2) [49].
There are additional bZIP proteins that recognize TRE/CRE half-
sites and are capable of interacting with bZIP proteins withdifferent DNA binding features [46]. Several ATF proteins form het-
erodimers with CCAAT/enhancer-binding proteins (C/EBPs) and can
have a composite element other than the merge of the two canon-
ical half-sites. Within the ATF4-specific C/EBP:ATF response ele-
ment (CARE), ATF4 binds a half-site with a unique spacer (50-TGA
(T)-30), while its partner binds the canonical C/EBP half-site (50-TT
(GC)-30) (Fig. 2) [31]. Interestingly, the C/EBP-bound genomic
regions contain a large number of motifs built up from a strong
and a weak C/EBP half-site, but this motif degeneracy is compen-
sated by shape features created by a directly upstream flanking
nucleotide of the half-sites, which can be any nucleotides other
than T. This nucleotide preference is characteristic of other bZIP
motifs, such as TRE/CRE half-sites, as well [31]. The binding of weak
motifs can also be supported by the neighboring elements, as in the
case of the promoter-proximal enhancer of inferferon-b (IFNB1)
[50]. In the TRE of this enhancer, ATF2 has extended interactions
within the major groove (50-TGA(C)-30), while JUN has a sub-
optimal – essentially unrecognizable and barely bound – half-site
(50-TAT(G)-30), which, in contrast, is optimal for minor groove bind-
ing by the neighboring IRF3. Interestingly, the downstream
interferon-stimulated response element (ISRE) is also unusual,
but this does not affect negatively the DNA-protein interactions
and the formation of the so-called enhanceosome [50]. Interaction
between AP-1 and IRF proteins is not restricted to this single site.
Several AP-1:IRF composite elements (AICEs) could be identified
in white blood cells, in which JUNB/BATF and IRF4/8 showed inter-
action at important immune response genes [51].7. Motif grammar of nuclear receptors
Specific and selective DNA binding by NRs is determined by
most aspects of motif grammar beyond the orientation and spac-
Fig. 3. Schematic representation of nuclear receptor motifs. The general (50-(A/G)GGTCA-30) and the NR3C steroid hormone receptor-specific (50-AGAACA-30) half-sites are
marked by blue or green arrows, respectively. 50 extensions are marked by cyan arrows, and spacer nucleotides are marked by black dots. Schematic motif logos and motif/
protein names are indicated (IR, inverted repeat; DR, direct repeat; ROR, retinoic acid receptor (RAR)-related orphan receptor; PPAR, peroxisome proliferator (PP)-activated
receptor; RXR, retinoid X receptor; VDR, vitamin D receptor; THR, thyroid hormone receptor; LXR, liver X receptor; ERE, estrogen response element; RORE, ROR response
element; PPRE, PP response element; VDRE, vitamin D response element; THRE, thyroid hormone response element; LXRE, LXR response element). (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of this article.)
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Basically, there are two types of NR half-sites. Most NRs bind vari-
ants of the 50-(A/G)GGTCA-30 consensus half-site, while members
of the NR3C steroid hormone receptor family have a 50-AGAACA-
30 consensus sequence (Fig. 3) [2]. All steroid hormone receptor
dimers bind IR elements separated by 3 nucleotides (IR3), and
the additional NR dimers recognize a complete series of DR ele-
ments with zero to at least five nucleotide long spacers (DR0-5).
Retinoic acid receptor (RAR, NR1B)/RXR heterodimers, for instance,
bind a wide range of elements, namely DR0, DR1, DR2, DR5, DR8
(DR2:DR0), and also IR0 elements [52–53]. Since most DR elements
can be bound by more than one dimer, in their case, specificity
should be made possible in other ways. Beyond their cell type-
specific gene expression and dimer conformation that allow the
recognition of different spacer lengths, NRs also adapted to addi-
tional sequence features, primarily the quality of the half-sites
and their flanking sequences (Fig. 3).
Certain NRs recognize a half-site longer than the consensus hex-
amer. All these sequences are extended upstream and some of
them can be part of DR elements and thus serve specific motif
recognition by NR dimers. Peroxisome proliferator (PP)-activated
receptors (PPARs, NR1C), REV-ERB proteins (NR1D), and RAR-
related orphan receptors (RORs, NR1F) belong to different NR
classes based on their dimerization and DNA binding features,
but all of these prefer 50-(A)A(C/G)T(A/G)GGTCA-30 sequences over
shorter half-sites (Fig. 3). These NRs have a carboxy-terminal
extension (CTE) of their DBD, and this interacts with the minor
groove upstream to the DBD-bound half-site [8,54]. Thereby
PPAR/RXR heterodimers bind extended DR1 elements (PPREs) with
higher affinity than other DR1s, and the other DR1-binding NRs,
such as hepatocyte nuclear factor 4 (HNF4, NR2A) and testicular
orphan receptor (TR, NR2C) dimers, might prefer DR1 elements
with other features [2,55]. Similarly, REV-ERB dimers prefer DR2
elements with 50-A(C/G)T-30 extensions both upstream to theDR2 and within the spacer (Rev-DR2s) [54]. As a result, the mono-
meric RORs are capable of PPRE and Rev-DR2 binding, which both
include the ROR response element (RORE), and REV-ERBs are cap-
able of repressing both on single ROREs and PPREs, which has func-
tional consequences in the regulation of the circadian rhythm of
the cells [56].
Besides these related NR families, there are additional ones with
sequence preference within the minor groove. These all form het-
erodimers with RXR, bind the downstream half-site, and thus their
specific 50 extensions are in the spacer of DR elements (Fig. 3).
Interestingly, liver X receptors (LXRs, NR1H2-3) have an extension
similar to that of ROREs despite the significant structural differ-
ences. The DR4 of RXR/LXR (LXRE) contains a spacer with a pre-
ferred 50-CTNN-30 sequence, which is bound by the amino-
terminal extension (NTE) of LXR [57,58]. In contrast, in the case
of the vitamin D receptor (VDR, NR1I1) and thyroid hormone
receptors (THRs, NR1A), the CTE of DBD has an alpha-helical struc-
ture that crosses the minor groove in the spacer of DR3 or DR4,
respectively [59,60]. The CTE helix of THR interacts with more
phosphate groups of both strands and the first two nucleotides of
the 30 half-site in the minor groove, yet it has a preferred nucleo-
tide within the spacer, of which general sequence is 50-NN(T/C)
N-30 [61]. VDR has an alternative, 7-nucleotide long 30 half-site
with a 50-G(A/G)G(T/G)TCA-30 consensus sequence, of which begin-
ning shows similar interactions with the CTE helix as observed in
the case of THR [60,62].
The last class of NRs is the monomeric orphan receptors, which
theoretically have a single half-site to bind, but since the variants
of this consensus hexamer are very frequent and thus cannot pro-
vide specificity, these NRs – including RORs – also have 50 extended
monomer binding sites. As a result, NR4A proteins require a 50-AA-
30 extension, and NR3B and NR5A proteins require a 50-CA-30
extension beyond the NR ‘‘half-site” (Fig. 3) [63–65]. This means
that except for NR0B proteins, which have no complete DBD allow-
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half-site described, although this is one of the least examined NR
family.
Not only the monomeric, but also the dimeric NRs show motif
degeneracy, although typically only one half-site is affected, and
one strong half-site is required for stable DNA binding, like in the
case of the C/EBP dimer binding sites. In the so-called half-site
binding mode any half-site can provide strong DNA-protein inter-
action, and this contributes to the recruitment of the dimerizing
partner with the weak half-site [66]. In the case of PPREs, both
the PPAR and RXR half-site can be extended, and these provide
more frequent binding than the weak and non-extended ones
[67]. Importantly, half-site binding mode is dominant over the full
site mode in the PPARc cistrome of macrophages and adipocytes,
which can be part of the optimization of enhancers to fulfill their
gene regulatory roles but involves major technical limitations in
the determination of sequence-specific direct binding events.8. Summary and outlook
Naturally, our understanding of DNA-TF interactions is limited
by the methodologies used. Initially, a few model or canonical sites
were used for molecular biology and biochemical studies. These
put restriction on and provided bias to building the motif gram-
mar. In the last two decades, several ex vivo high-throughput
methods, such as protein-binding microarrays, systematic evolu-
tion of ligands by exponential enrichment (SELEX)-based methods,
and DNA affinity purification sequencing (DAP-seq) were devel-
oped to characterize the sequence features determining DNA bind-
ing by TFs. These showed not only the sequences optimal for DNA-
TF interactions, but also their DNA methylation dependence, a
wide range of possible TF-TF interactions through composite ele-
ments, as well as the significance of half-site binding mode
[7,15,27,66]. However, due to the fact that these cannot take live
cellular conditions – such as the neighboring or farther interacting
sequences and the concentration of collaborating or competing TFs
and other chromatin components – into consideration, several fea-
tures, for instance those allowing the binding of suboptimal sites,
could not be broadly tested. A successful way to investigate this
phenomenon is to compare organisms with different genotypes
or generate mutants and show the alterations in DNA binding –
although these are not high-throughput approaches [22–25]. In
contrast, the availability of cistromic (chromatin immunoprecipi-
tation sequencing, ChIP-seq) data sets allows an unbiased assess-
ment, although it is always a great challenge to discriminate
direct and indirect DNA binding events, since bioinformatic
approaches typically cannot identify weak binding sites, although
these can be as functional as canonical elements in certain condi-
tions. Identifying all functional units of regulatory regions requires
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